GE HEALTHCARE TECHNOLOGIES INC. (GEHC) Current Ratio
- Current ratio · latest quarter: Value 1.22×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-03-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 1.22× | Current assets / current liabilities. $10.43B ÷ $8.53B ≈ 1.22× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 10.43B USD | Assets, Current |
| Current obligations | 8.53B USD | Liabilities, Current |
| Cash and equivalents | 2.26B USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | (m) | |
| Inventory | 2.35B USD | Inventory, Net |
| Payables | 3.41B USD | Accounts Payable, Current |
| Borrowing debt due within one year | 2.00M USD | Long-term Debt, Current Maturities |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | $10.43B | $8.53B | $2.26B | (m) | (m) | $2.35B | $3.41B | $2.00M | 1.22× |
| 2025-12-31 | $12.50B | $9.11B | $4.49B | (m) | (m) | $2.23B | $3.25B | $502.00M | 1.37× |
| 2025-09-30 | $11.89B | $10.07B | $4.00B | (m) | (m) | $2.30B | $2.99B | $2.00B | 1.18× |
| 2025-06-30 | $11.31B | $9.75B | $3.74B | (m) | (m) | $2.28B | $2.98B | $2.00B | 1.16× |
| 2025-03-31 | $9.73B | $9.97B | $2.45B | (m) | (m) | $2.16B | $3.15B | $2.00B | 0.98× |
| 2024-12-31 | $9.90B | $9.55B | $2.87B | (m) | (m) | $1.94B | $3.04B | $1.50B | 1.04× |
| 2024-09-30 | $10.64B | $8.67B | $3.55B | (m) | (m) | $2.12B | $2.91B | $1.00B | 1.23× |
| 2024-06-30 | $8.81B | $8.32B | $2.00B | (m) | (m) | $2.02B | $2.82B | $1.00B | 1.06× |
| 2024-03-31 | $9.37B | $8.86B | $2.55B | (m) | (m) | $1.99B | $2.93B | $1.00B | 1.06× |
| 2023-12-31 | $9.41B | $8.98B | $2.49B | (m) | (m) | $1.96B | $2.95B | $1.00B | 1.05× |
| 2023-09-30 | $9.47B | $7.57B | $2.41B | (m) | (m) | $2.13B | $2.77B | $7.00M | 1.25× |
| 2023-06-30 | $9.24B | $7.58B | $1.94B | (m) | (m) | $2.26B | $2.83B | $5.00M | 1.22× |
| 2023-03-31 | $9.60B | $8.24B | $2.32B | (m) | (m) | $2.26B | $2.98B | $5.00M | 1.17× |
| 2022-12-31 | $8.32B | $7.19B | $1.44B | (m) | (m) | $2.15B | $2.94B | (m) | 1.16× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.